FR2515041A1 - Medicament a base de progesterone pour le traitement des affections mammaires - Google Patents
Medicament a base de progesterone pour le traitement des affections mammaires Download PDFInfo
- Publication number
- FR2515041A1 FR2515041A1 FR8120034A FR8120034A FR2515041A1 FR 2515041 A1 FR2515041 A1 FR 2515041A1 FR 8120034 A FR8120034 A FR 8120034A FR 8120034 A FR8120034 A FR 8120034A FR 2515041 A1 FR2515041 A1 FR 2515041A1
- Authority
- FR
- France
- Prior art keywords
- progesterone
- treatment
- group
- medicinal product
- based drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims description 5
- 229940079593 drug Drugs 0.000 title description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title description 2
- 201000010099 disease Diseases 0.000 title 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 claims abstract description 34
- 229960003387 progesterone Drugs 0.000 claims abstract description 17
- 239000000186 progesterone Substances 0.000 claims abstract description 17
- 206010006298 Breast pain Diseases 0.000 claims abstract description 10
- 229940126601 medicinal product Drugs 0.000 claims abstract 5
- 208000030270 breast disease Diseases 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 239000008213 purified water Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 abstract description 7
- 208000006662 Mastodynia Diseases 0.000 abstract description 6
- 229940011871 estrogen Drugs 0.000 description 3
- 239000000262 estrogen Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010006312 Breast swelling Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 206010046798 Uterine leiomyoma Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000027758 ovulation cycle Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8120034A FR2515041A1 (fr) | 1981-10-26 | 1981-10-26 | Medicament a base de progesterone pour le traitement des affections mammaires |
| GB08229804A GB2109231A (en) | 1981-10-26 | 1982-10-19 | Medicament containing progesterone |
| DE19823238984 DE3238984A1 (de) | 1981-10-26 | 1982-10-21 | Arzneimittel auf basis von progesteron |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8120034A FR2515041A1 (fr) | 1981-10-26 | 1981-10-26 | Medicament a base de progesterone pour le traitement des affections mammaires |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2515041A1 true FR2515041A1 (fr) | 1983-04-29 |
| FR2515041B3 FR2515041B3 (enrdf_load_stackoverflow) | 1984-06-15 |
Family
ID=9263374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8120034A Granted FR2515041A1 (fr) | 1981-10-26 | 1981-10-26 | Medicament a base de progesterone pour le traitement des affections mammaires |
Country Status (3)
| Country | Link |
|---|---|
| DE (1) | DE3238984A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2515041A1 (enrdf_load_stackoverflow) |
| GB (1) | GB2109231A (enrdf_load_stackoverflow) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2558373A1 (fr) * | 1984-01-20 | 1985-07-26 | Mauvais Jarvis Pierre | Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee |
| WO1998037897A1 (en) * | 1997-02-26 | 1998-09-03 | Dimera, Llc | Method for reducing coronary artery reactivity |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744463A (en) * | 1996-06-03 | 1998-04-28 | Bair; Glenn O. | Treatment of side effects of progestins and progesterone analogues used for birth control |
| ATE279916T1 (de) | 1996-07-22 | 2004-11-15 | Renovo Ltd | Verwendung von substanzen, die die östrogen wirkung fördern, zur behandlung von wunden |
| DE19908762A1 (de) * | 1999-02-18 | 2000-08-31 | Jenapharm Gmbh | Verwendung von Dienogest in hoher Dosierung |
| US7968532B2 (en) | 2003-12-15 | 2011-06-28 | Besins Healthcare Luxembourg | Treatment of gynecomastia with 4-hydroxy tamoxifen |
| EP1579856A1 (en) * | 2004-03-22 | 2005-09-28 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| US7507769B2 (en) | 2004-03-22 | 2009-03-24 | Laboratoires Besins International | Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |
| MXPA06010914A (es) * | 2004-03-22 | 2006-12-15 | Besins Int Lab | Tratamiento y prevencion de enfermedades de mama benigna con 4-hidroxi tamoxifen. |
| AU2006299833B2 (en) | 2005-10-12 | 2012-04-12 | Besins Healthcare Luxembourg Sarl | Improved testosterone gel and method of use |
| DE102008064534A1 (de) * | 2008-12-29 | 2010-07-15 | Reimers, Simon | Mobil-Aufrecht-Fahr-System |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1047518A (en) * | 1963-06-11 | 1966-11-02 | Glaxo Lab Ltd | 17ª-monoesters of 11,17,21-trihydroxy steroid compounds |
| US4136173A (en) * | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Mixed xanthan gum and locust beam gum therapeutic compositions |
| DE2964471D1 (en) * | 1979-06-08 | 1983-02-17 | Toko Yakuhin Kogyo Kk | Creamy preparation containing steroid and process for the preparation thereof |
-
1981
- 1981-10-26 FR FR8120034A patent/FR2515041A1/fr active Granted
-
1982
- 1982-10-19 GB GB08229804A patent/GB2109231A/en not_active Withdrawn
- 1982-10-21 DE DE19823238984 patent/DE3238984A1/de active Granted
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2558373A1 (fr) * | 1984-01-20 | 1985-07-26 | Mauvais Jarvis Pierre | Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee |
| WO1985003228A1 (fr) * | 1984-01-20 | 1985-08-01 | Mauvais Jarvis Pierre | Medicament antioestrogene pour administration percutanee |
| EP0151326A1 (fr) * | 1984-01-20 | 1985-08-14 | Pierre Mauvais-Jarvis | Médicament antioestrogène pour administration percutanée |
| US4919937A (en) * | 1984-01-20 | 1990-04-24 | Mauvais Jarvis Pierre | Percutaneous administration of tamoxifen |
| WO1998037897A1 (en) * | 1997-02-26 | 1998-09-03 | Dimera, Llc | Method for reducing coronary artery reactivity |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2109231A (en) | 1983-06-02 |
| DE3238984A1 (de) | 1983-05-05 |
| DE3238984C2 (enrdf_load_stackoverflow) | 1991-12-19 |
| FR2515041B3 (enrdf_load_stackoverflow) | 1984-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101545366B1 (ko) | 천심련 추출물 | |
| KR100459747B1 (ko) | 로제시아치료제 | |
| EP1871399B1 (fr) | Utilisation de la lecithine comme medicament dans le traitement du psoriasis | |
| WO2002036592A1 (fr) | Remedes aux maladies causees par l'acide arachidonique | |
| FR2515041A1 (fr) | Medicament a base de progesterone pour le traitement des affections mammaires | |
| KR100685696B1 (ko) | 활성 성분으로 조효소 ｑ를 함유하는 경점막 투여용 조성물 | |
| FR2518879A1 (fr) | Medicament a base d'oestradiol pour le traitement de la pathologie menopausique | |
| EP0679392A1 (fr) | Nouvelle forme galénique pour l'administration transdermique | |
| OA10411A (fr) | Nouveaux médicaments hormonaux et leur utilisation pour la correction des carences estrogéniques | |
| US20050181057A1 (en) | Vaginal lubricant | |
| RU2564944C1 (ru) | Мазь с метронидазолом, экстрактом личинок большой восковой моли и анестезином для комплексного лечения воспалительных заболеваний пародонта | |
| BE903646A (fr) | Composition pour le traitement et l'entretien de la peau | |
| EP0113608A1 (fr) | Association permettant d'améliorer l'absorption de divers cations | |
| JP2860550B2 (ja) | 急性皮膚炎症治療剤 | |
| DE102004023984A1 (de) | Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol | |
| CN113453758A (zh) | 脉管异常治疗用外用剂 | |
| FR2758460A1 (fr) | Utilisation des agonistes des recepteurs beta-3 adrenergiques pour la preparation de medicaments cicatrisants | |
| KR20060066177A (ko) | 데커신 및/또는 데커시놀 안젤레이트, 또는 데커신및/또는 데커시놀 안젤레이트를 유효성분으로 하는당귀추출물을 포함하는 간기능 치료제 조성물 | |
| DE69923982T2 (de) | Verwendung einer zusammensetzung enthaltend eine assoziation eines angiotensin ii at1 rezeptor antagonists und indomethacin zur herstellung eines arzneimittels zur behandlung von kronischen glomerulonephriten | |
| FR2589735A1 (fr) | Compositions anticonceptionnelles contenant un oestrogene et un progestatif | |
| JPH0796488B2 (ja) | 白髪黒化剤 | |
| JP2003192599A (ja) | 早漏および／または性的刺激過敏症の予防及び治療用組成物 | |
| DE69819503T2 (de) | Verwendung eines 7-alpha-methyl-17-alpha-ethinyl-östran-derivats zur behandlung von arteriosklerose | |
| JP3507515B2 (ja) | エストリオールの高血中濃度が得られる軟膏剤 | |
| CN1225581A (zh) | α阻断剂的应用,尤其是百里胺和/或其衍生物通过龟头透粘膜途径治疗阴茎勃起功能障碍 |